Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
暂无分享,去创建一个
[1] H. Griffiths,et al. The dual role of Reactive Oxygen Species in autoimmune and inflammatory diseases: evidence from preclinical models , 2018, Free radical biology & medicine.
[2] J. Sibilia,et al. Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation , 2018, Front. Immunol..
[3] W. Weaver,et al. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy , 2018, Neurology.
[4] K. Griendling,et al. Reactive Oxygen Species in Metabolic and Inflammatory Signaling. , 2018, Circulation research.
[5] Hiroyasu Ito,et al. Activation of NLRP3 signalling accelerates skin wound healing , 2018, Experimental dermatology.
[6] D. Leavesley,et al. Xanthine Oxidoreductase: A Novel Therapeutic Target for the Treatment of Chronic Wounds? , 2017, Advances in wound care.
[7] A. Nurden. The biology of the platelet with special reference to inflammation, wound healing and immunity. , 2018, Frontiers in bioscience.
[8] E. Yow,et al. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide , 2017, Circulation. Heart failure.
[9] T. Kyriakides,et al. Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition. , 2017, Antioxidants & redox signaling.
[10] P. Guillausseau,et al. Activation of the receptor for advanced glycation end products and consequences on health. , 2017, Diabetes & metabolic syndrome.
[11] M. Pepper,et al. Reactive Oxygen Species and NOX Enzymes Are Emerging as Key Players in Cutaneous Wound Repair , 2017, International journal of molecular sciences.
[12] Piul S. Rabbani,et al. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus , 2017, Journal of diabetes research.
[13] B. Chernyak,et al. Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice , 2017, Oxidative medicine and cellular longevity.
[14] R. Z. Murray,et al. Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing , 2017, International journal of molecular sciences.
[15] R. Neviere,et al. Kidney, heart and brain: three organs targeted by ageing and glycation. , 2017, Clinical science.
[16] P. Schumacker,et al. Redox signaling during hypoxia in mammalian cells , 2017, Redox biology.
[17] Y. Pan,et al. Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor‐3 and downregulates nuclear factor‐κB in diabetic patients with foot ulcerations , 2017, Diabetes/metabolism research and reviews.
[18] Shuliang Lu,et al. Hydrogen Peroxide: A Potential Wound Therapeutic Target , 2017, Medical Principles and Practice.
[19] B. Brüne,et al. Mitochondrial composition and function under the control of hypoxia , 2017, Redox biology.
[20] S. Yamagishi,et al. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory , 2017, Journal of diabetes.
[21] J. Cooke,et al. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS‐modulating technologies for augmentation of the healing process , 2017, International wound journal.
[22] Y. Chai,et al. NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages , 2017, Journal of diabetes research.
[23] A. Galandáková,et al. Models for the study of skin wound healing. The role of Nrf2 and NF-κB. , 2017, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[24] Jin Han,et al. Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders. , 2017, Advances in experimental medicine and biology.
[25] P. Reddy,et al. Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease. , 2017, Progress in molecular biology and translational science.
[26] P. Moortgat,et al. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review , 2016, Scars, burns & healing.
[27] J. Janis,et al. Wound Healing: Part I. Basic Science , 2016, Plastic and reconstructive surgery.
[28] K. Krause,et al. NADPH oxidase 4 deficiency leads to impaired wound repair and reduced dityrosine-crosslinking, but does not affect myofibroblast formation. , 2016, Free radical biology & medicine.
[29] Lei Wang,et al. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions , 2016, Glycoconjugate Journal.
[30] M. Brownlee,et al. Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. , 2016, Circulation research.
[31] M. Ståhle,et al. Transition from inflammation to proliferation: a critical step during wound healing , 2016, Cellular and Molecular Life Sciences.
[32] P. Schumacker,et al. O2 sensing, mitochondria and ROS signaling: The fog is lifting. , 2016, Molecular aspects of medicine.
[33] A. Chandra,et al. Biomarkers for wound healing and their evaluation. , 2016, Journal of wound care.
[34] E. Caterson,et al. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. , 2014, Advances in wound care.
[35] Piul S. Rabbani,et al. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche , 2015, Diabetes.
[36] K. Jandeleit-Dahm,et al. Linking RAGE and Nox in diabetic micro- and macrovascular complications. , 2015, Diabetes & metabolism.
[37] D. Baker,et al. The innate immune system, toll-like receptors and dermal wound healing: A review. , 2015, Vascular pharmacology.
[38] Ş. Coşkun-Cevher,et al. A bioactive molecule in a complex wound healing process: platelet‐derived growth factor , 2015, International journal of dermatology.
[39] A. Poole,et al. Platelet secretion: From haemostasis to wound healing and beyond , 2015, Blood reviews.
[40] M. Longaker,et al. Emerging drugs for the treatment of wound healing , 2015, Expert opinion on emerging drugs.
[41] T. Koh,et al. Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing , 2015, PloS one.
[42] Andrew L. Weinstein,et al. Normalizing dysfunctional purine metabolism accelerates diabetic wound healing , 2015, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[43] Y. Tokura,et al. Attempts to accelerate wound healing. , 2014, Journal of dermatological science.
[44] S. Sollott,et al. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.
[45] M. Banerjee,et al. Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus☆ , 2013, Redox biology.
[46] Donna D. Zhang,et al. The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV , 2013, Redox biology.
[47] P. Bainbridge,et al. Wound healing and the role of fibroblasts. , 2013, Journal of wound care.
[48] J. Ha,et al. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines , 2013, BMC Medicine.
[49] J. Ather,et al. Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status. , 2013, Free radical biology & medicine.
[50] J. Rosado,et al. Molecular interplay between platelets and the vascular wall in thrombosis and hemostasis. , 2013, Current vascular pharmacology.
[51] N. Žarković,et al. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation , 2013, Free radical research.
[52] C. Artlett. Inflammasomes in wound healing and fibrosis , 2013, The Journal of pathology.
[53] P. Galéra,et al. NF-κB accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a -112/-61-bp region of the COL1A1 promoter in human skin fibroblasts. , 2012, The Journal of investigative dermatology.
[54] Yves Bayon,et al. Reactive oxygen species (ROS)--a family of fate deciding molecules pivotal in constructive inflammation and wound healing. , 2012, European cells & materials.
[55] Michael R Hamblin,et al. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery. , 2012, Advances in skin & wound care.
[56] T. Guzik,et al. Targeting NADPH oxidases in vascular pharmacology. , 2012, Vascular pharmacology.
[57] F. Al-Mulla,et al. A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes. , 2011, American journal of physiology. Endocrinology and metabolism.
[58] D. Gutterman,et al. ROS-induced ROS release in vascular biology: redox-redox signaling. , 2011, American journal of physiology. Heart and circulatory physiology.
[59] G. Dusting,et al. NADPH Oxidase-Mediated Redox Signaling: Roles in Cellular Stress Response, Stress Tolerance, and Tissue Repair , 2011, Pharmacological Reviews.
[60] R. Sivamani,et al. Antioxidant Therapies for Wound Healing: A Clinical Guide to Currently Commercially Available Products , 2011, Skin Pharmacology and Physiology.
[61] P. Pelicci,et al. The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing , 2010, Diabetes.
[62] S. Kondo,et al. Spontaneous skin damage and delayed wound healing in SOD1-deficient mice , 2010, Molecular and Cellular Biochemistry.
[63] L. DiPietro,et al. Factors Affecting Wound Healing , 2010, Journal of dental research.
[64] A. Fukamizu,et al. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[65] M. Peppa,et al. Advanced glycoxidation products and impaired diabetic wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[66] Chandan K Sen,et al. Wound healing essentials: Let there be oxygen , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[67] C. Sen,et al. Redox signals in wound healing. , 2008, Biochimica et biophysica acta.
[68] Shuliang Lu,et al. Effects of Extracellular Matrix Glycosylation on Proliferation and Apoptosis of Human Dermal Fibroblasts Via the Receptor for Advanced Glycosylated End Products , 2008, The American Journal of dermatopathology.
[69] Matthias Schäfer,et al. Oxidative stress in normal and impaired wound repair. , 2008, Pharmacological research.
[70] M. Huijberts,et al. Advanced glycation end products and diabetic foot disease , 2008, Diabetes/metabolism research and reviews.
[71] G. Siegal,et al. Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism , 2007, The Journal of experimental medicine.
[72] Alex F Chen,et al. Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice , 2004, Circulation.
[73] A. Schmidt,et al. Use of Topical sRAGE in Diabetic Wounds Increases Neovascularization and Granulation Tissue Formation , 2004, Annals of plastic surgery.
[74] M. Peppa,et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.
[75] T. Kislinger,et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.